We Just Had An Epiphany

Tag: Turnaround Stocks

Digital illustration of Teladoc logo glowing over a hospital screen with stock charts and a rocket lifting off, symbolizing turnaround hopes.

Year-Old CEO Could Start Making an Impact: Can Teladoc (TDOC) Reboot Growth, Turn a Profit, and Send Its Stock Back to the Moon?

Teladoc Health is down 97% from ATH — but Citron says Livongo is booming, institutions are buying, and the CEO just hit his one-year mark. Bargain bin or value trap?

 

Read entire article

Tags: AI in healthcare, ARKK stocks, BetterHelp, Chuck Divita, Citron Research, contrarian investing, Contrarian Investments, Contrarian Picks, Contrarian Play, ContrarianStocks, Funanc1al, FUNanc1al Edge, Funanc1al Humor, Funanc1al Investing, healthcare investing, institutional ownership, Livongo, New CEO, New Management, TDOC stock, Teladoc, telehealth, turnaround stocks
Playful illustration of a Peloton bike with dollar-bill pedals spinning on Wall Street’s trading floor, traders sweating, Netflix-dumbbell in the bg, and institutions cheering while insiders hold ‘SOLD’ signs — symbolizing Peloton’s wild stock ride.

Peloton Interactive (PTON): Can This Fitness Unicorn Get Its Groove Back?

Peloton (PTON) is no longer just a bike company—it’s trying to pivot into a full wellness platform. Institutions are buying, shorts are circling, and the new CEO is bringing Apple/Ford cred. But can Peloton spin its way back to growth, or is this ride still too risky?

Read entire article

Tags: Contrarian Investment, Fitness Stocks, Funanc1al, Funanc1al Edge, Funanc1al Humor, Funanc1al Investing, Insider Buying, Insider Selling, Institutional Ownership, New CEO, Peloton, Peloton Stock, Peter Stern, PTON, Speculative Buy, Turnaround Play, Turnaround Stocks, Wellness Stocks